Cargando…
Validation of a vision-related activity scale for patients with retinitis pigmentosa
PURPOSE: There have been few systematic reports of vision-related activity limitations of people with retinitis pigmentosa (RP). We report a merging of data from the National Eye Institute Visual Function Questionnaire (NEI-VFQ) obtained in five previous studies. We asked whether the Vision Function...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310073/ https://www.ncbi.nlm.nih.gov/pubmed/32571342 http://dx.doi.org/10.1186/s12955-020-01427-8 |
_version_ | 1783549299643121664 |
---|---|
author | Costela, Francisco M. Pesudovs, Konrad Sandberg, Michael A. Weigel-DiFranco, Carol Woods, Russell L. |
author_facet | Costela, Francisco M. Pesudovs, Konrad Sandberg, Michael A. Weigel-DiFranco, Carol Woods, Russell L. |
author_sort | Costela, Francisco M. |
collection | PubMed |
description | PURPOSE: There have been few systematic reports of vision-related activity limitations of people with retinitis pigmentosa (RP). We report a merging of data from the National Eye Institute Visual Function Questionnaire (NEI-VFQ) obtained in five previous studies. We asked whether the Vision Function Scale (VFS; Pesudovs et al., 2010) which was developed for cataract patients would apply in this new population (condition). METHODS: Five hundred ninety-four individuals completed a total of 1753 questionnaires, with 209 participants providing responses over at least 4 years. Rasch analysis showed that the 15-item VFS was poorly targeted. A new instrument created by adding four driving-related items to the VFS had better targeting. As an indirect validation, VFS-plus person scores were compared to visual field area measured using a Goldmann perimeter, to the summed score for the combined 30–2 and 30/60–1 Humphrey Field Analyzer programs (HFA), to 30-Hz full-field cone electroretinogram (ERG) amplitude, and to ETDRS visual acuity. Changes in VFS-plus person scores with age and between four common heredity groups were also examined. RESULTS: The Rasch model of responses to the 19 VFS-plus items had person and item separation of 2.66 and 24.43 respectively. The VFS-plus person scores were related to each vision measure (p < 0.001). Over a five-year period, there was a reduction in person scores of 0.5 logits (p < 0.001). Person scores fell by an average of 0.34 logits per decade (p < 0.0001). Participants with an X-linked hereditary pattern had, on average, lower person scores (p < 0.001). CONCLUSIONS: The VFS-plus instrument quantified a highly-significant annual reduction in perceived vision-related ability over a five-year period. The outcome was consistent with clinical measures of vision, and detected lower perceived vision-related ability in participants with X-linked disease. It may be of use in future studies, but this needs to be tested in a representative population sample. |
format | Online Article Text |
id | pubmed-7310073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73100732020-06-23 Validation of a vision-related activity scale for patients with retinitis pigmentosa Costela, Francisco M. Pesudovs, Konrad Sandberg, Michael A. Weigel-DiFranco, Carol Woods, Russell L. Health Qual Life Outcomes Research PURPOSE: There have been few systematic reports of vision-related activity limitations of people with retinitis pigmentosa (RP). We report a merging of data from the National Eye Institute Visual Function Questionnaire (NEI-VFQ) obtained in five previous studies. We asked whether the Vision Function Scale (VFS; Pesudovs et al., 2010) which was developed for cataract patients would apply in this new population (condition). METHODS: Five hundred ninety-four individuals completed a total of 1753 questionnaires, with 209 participants providing responses over at least 4 years. Rasch analysis showed that the 15-item VFS was poorly targeted. A new instrument created by adding four driving-related items to the VFS had better targeting. As an indirect validation, VFS-plus person scores were compared to visual field area measured using a Goldmann perimeter, to the summed score for the combined 30–2 and 30/60–1 Humphrey Field Analyzer programs (HFA), to 30-Hz full-field cone electroretinogram (ERG) amplitude, and to ETDRS visual acuity. Changes in VFS-plus person scores with age and between four common heredity groups were also examined. RESULTS: The Rasch model of responses to the 19 VFS-plus items had person and item separation of 2.66 and 24.43 respectively. The VFS-plus person scores were related to each vision measure (p < 0.001). Over a five-year period, there was a reduction in person scores of 0.5 logits (p < 0.001). Person scores fell by an average of 0.34 logits per decade (p < 0.0001). Participants with an X-linked hereditary pattern had, on average, lower person scores (p < 0.001). CONCLUSIONS: The VFS-plus instrument quantified a highly-significant annual reduction in perceived vision-related ability over a five-year period. The outcome was consistent with clinical measures of vision, and detected lower perceived vision-related ability in participants with X-linked disease. It may be of use in future studies, but this needs to be tested in a representative population sample. BioMed Central 2020-06-22 /pmc/articles/PMC7310073/ /pubmed/32571342 http://dx.doi.org/10.1186/s12955-020-01427-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Costela, Francisco M. Pesudovs, Konrad Sandberg, Michael A. Weigel-DiFranco, Carol Woods, Russell L. Validation of a vision-related activity scale for patients with retinitis pigmentosa |
title | Validation of a vision-related activity scale for patients with retinitis pigmentosa |
title_full | Validation of a vision-related activity scale for patients with retinitis pigmentosa |
title_fullStr | Validation of a vision-related activity scale for patients with retinitis pigmentosa |
title_full_unstemmed | Validation of a vision-related activity scale for patients with retinitis pigmentosa |
title_short | Validation of a vision-related activity scale for patients with retinitis pigmentosa |
title_sort | validation of a vision-related activity scale for patients with retinitis pigmentosa |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310073/ https://www.ncbi.nlm.nih.gov/pubmed/32571342 http://dx.doi.org/10.1186/s12955-020-01427-8 |
work_keys_str_mv | AT costelafranciscom validationofavisionrelatedactivityscaleforpatientswithretinitispigmentosa AT pesudovskonrad validationofavisionrelatedactivityscaleforpatientswithretinitispigmentosa AT sandbergmichaela validationofavisionrelatedactivityscaleforpatientswithretinitispigmentosa AT weigeldifrancocarol validationofavisionrelatedactivityscaleforpatientswithretinitispigmentosa AT woodsrusselll validationofavisionrelatedactivityscaleforpatientswithretinitispigmentosa |